Five Oceans Advisors’s AstraZeneca AZN Stock Holding History

Five Oceans Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$650K	Buy	4,026 +17	+0.4%	+$2.83K	0.25%	53
2026 Q2	$760K	Buy	4,009 +6	+0.1%	+$1.13K	0.24%	54
2026 Q1	$789K	Buy	4,003 +6	+0.2%	+$1.16K	0.29%	43
2025 Q4	$735K	Hold	3,997	–	–	0.26%	48
2025 Q3	$613K	Buy	3,997 +201	+5%	+$30.4K	0.23%	56
2025 Q2	$531K	Hold	3,796	–	–	0.23%	57
2025 Q1	$558K	Sell	3,796 -1,172	-24%	-$170K	0.27%	56
2024 Q4	$651K	Buy	4,968 +530	+12%	+$74.2K	0.3%	53
2024 Q3	$692K	Buy	4,438 +359	+9%	+$58K	0.33%	53
2024 Q2	$636K	Buy	4,079 +596	+17%	+$89.7K	0.33%	52
2024 Q1	$472K	Hold	3,483	–	–	0.24%	68
2023 Q4	$469K	Buy	3,483 +41	+1%	+$5.33K	0.26%	71
2023 Q3	$466K	Hold	3,442	–	–	0.3%	67
2023 Q2	$493K	Hold	3,442	–	–	0.32%	69
2023 Q1	$478K	Hold	3,442	–	–	0.31%	74
2022 Q4	$467K	Sell	3,442 -1	-0%	-$125	0.32%	70
2022 Q3	$378K	Buy	3,443 +1,230	+56%	+$156K	0.3%	73
2022 Q2	$292K	Buy	2,213 +199	+10%	+$26.1K	0.22%	91
2022 Q1	$267K	Hold	2,014	–	–	0.24%	85
2021 Q4	$235K	Sell	2,014 -20	-1%	-$2.35K	0.21%	92
2021 Q3	$244K	Buy	+2,034	New	+$237K	0.28%	79

Other funds holding AZN

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Five Oceans Advisors's AZN Position: Q3 2026 in Review

Five Oceans Advisors increased its AstraZeneca (AZN) stake by 0.42% in Q3 2026, buying an estimated $2.83K and bringing the position to 4,026 shares worth $650K. The position accounts for 0.25% of the portfolio, ranked #53.

Five Oceans Advisors first reported a position in AZN in Q3 2021 and has held it in 21 quarters since. The position peaked at $789K in Q1 2026. 347 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Five Oceans Advisors held 4,026 shares of AstraZeneca worth $650K as of Q3 2026.
Five Oceans Advisors bought 17 AstraZeneca shares in Q3 2026, an estimated $2.83K.
AstraZeneca made up 0.25% of Five Oceans Advisors's portfolio in Q3 2026, its #53 holding.
Five Oceans Advisors first reported a position in AstraZeneca in Q3 2021 and has held it in 21 quarters since.
Five Oceans Advisors's AstraZeneca position peaked at $789K in Q1 2026.
347 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Five Oceans Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.